Pulmonary cryptococcosis in a patient with Crohn's disease treated with prednisone, azathioprine and adalimumab: Exposure to chicken manure as a source of contamination

Journal of Crohn's and Colitis

Volumn 7, Issue 1, 2013, Pages

  Fraison, Jean Baptiste ^a   Guilpain, Philippe ^a   Schiffmann, Aurélie ^a   Veyrac, Michel ^a   Le Moing, Vincent ^a   Rispail, Philippe ^a   Le Quellec, Alain ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Adalimumab; Chickens; Crohn's disease; Cryptococcosis; Manure

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; FLUCONAZOLE; FLUCYTOSINE; INFLIXIMAB; PREDNISONE;

ABDOMINAL PAIN; ADULT; ANAPHYLACTIC SHOCK; ANKYLOSING SPONDYLITIS; ANXIETY DISORDER; ARTICLE; CASE REPORT; CHICKEN; CROHN DISEASE; DIARRHEA; DISEASE CARRIER; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENVIRONMENTAL EXPOSURE; GLAUCOMA; HOSPITAL ADMISSION; HUMAN; LUNG LAVAGE; MALE; MANURE; PRIORITY JOURNAL; PULMONARY CRYPTOCOCCOSIS; RELAPSE; THORAX RADIOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIFUNGAL AGENTS; AZATHIOPRINE; CHICKENS; CROHN DISEASE; CRYPTOCOCCOSIS; ENVIRONMENTAL EXPOSURE; FECES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PREDNISONE;

EID: 84872147724     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.04.016     Document Type: Article

References (16)

1. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2078.
2. Sandborn W.J., Rutgeerts P., Enns R., Hanauer S.B., Colombel J.F., Panaccione R., et al. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med 2007, 146:829-838.
3. Marie I., Guglielmino E. Non tuberculous anti-TNF associated opportunistic infections. Rev Med Interne 2010, 31:353-360.
4. Tsiodras S., Samonis G., Boumpas D.T., Kontoyiannis D.P. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008, 83:181-194.
5. Singh N., Alexander B.D., Lortholary O., Dromer F., Gupta K.L., John G.T., et al. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis 2007, 195:756-764.
6. Husain S., Wagener M.M., Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001, 7:375-381.
7. Chang W.C., Tzao C., Hsu H.H., Lee S.C., Huang K.L., Tung H.J., et al. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest 2006, 129:333-340.
8. Perfect J.R., Dismukes W.E., Dromer F., Goldman D.L., Graybill J.R., Hamill R.J., et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010, 50:291-322.
9. Osawa R., Singh N. Colitis as a manifestation of infliximab-associated disseminated cryptococcosis. Int J Infect Dis 2010, 14:e436-e440.
10. Kozic H., Riggs K., Ringpfeil F., Lee J.B. Disseminated Cryptococcus neoformans after treatment with infliximab for rheumatoid arthritis. J Am Acad Dermatol 2008, 58:S95-S96.
11. Kluger N., Poirier P., Guilpain P., Baixench M.T., Cohen P., Paugam A. Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease. Int J Infect Dis 2009, 13:e325-e.
12. Chavez-Lopez M., Marquez-Diaz F., Aguayo-Leytte G. Cerebral cryptococcosis associated with etanercept. Enferm Infecc Microbiol Clin 2006, 24:288.
13. Saag M.S., Powderly W.G., Cloud G.A., Robinson P., Grieco M.H., Sharkey P.K., et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992, 326:83-89.
14. Probst C., Pongratz G., Capellino S., Szeimies R.M., Scholmerich J., Fleck M., et al. Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report. BMC Infect Dis 2010, 10:239.
15. Herring A.C., Lee J., McDonald R.A., Toews G.B., Huffnagle G.B. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun 2002, 70:2959-2964.
16. Lichtenstein G.R., Feagan B.G., Cohen R.D., Salzberg B.A., Diamond R.H., Chen D.M., et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006, 4:621-630.